DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Bioactive CompoundsBioactive Compounds
  4. /Anti-Infective AgentsAnti-Infective Agents
  5. /HCVHCV
  6. /Gsk-2336805Gsk-2336805
Chemical structure of CAS 1256390-53-0

Gsk-2336805

CAS No.1256390-53-0
MDL No.N/A
MFC42H52N8O8
MW796.90
InChI KeyYMCAVGXTSCNFDE-BBACVFHCSA-N
CUSTOM SYNTHESISPRECLINICAL SUPPORT→

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.1256390-53-0
Product NameGsk-2336805
Heavy Atom Count58Rotatable Bond Count11
Atom Stereo Count4Bond Stereo Count0
HBA10HBD4
TPSA193.100 ŲCharge0
Exact Mass796.39081Complexity2089.49
pKa5.875XLogP5.575

Related Articles

Studies related to this compound and its mechanism of action

Novel spiroketal pyrrolidine GSK2336805 potently inhibits key hepatitis C virus genotype 1b mutants: from lead to clinical compound.

Journal of medicinal chemistry • Vol. 57, Issue 5 • 2014
PMID: 24568313DOI: 10.1021/jm4013104

Documentation

Similar Products

  • Daclatasvir

    CAS No.1009119-64-5

  • Daclatasvir Dihydrochloride

    CAS No.1009119-65-6

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact